Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.86B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
Mercado Libre
MELI
|
+$1.59B |
| 4 |
TSMC
TSM
|
+$1.34B |
| 5 |
Coupang
CPNG
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$2.61B |
| 2 |
EPAM Systems
EPAM
|
+$1.48B |
| 3 |
Twilio
TWLO
|
+$1.35B |
| 4 |
Apple
AAPL
|
+$1.24B |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.54% |
| 2 | Healthcare | 9.8% |
| 3 | Financials | 9.16% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4201
Rimini Street
RMNI
$466M
| $2.6M | ﹤0.01% |
449,021
+19,012
| +4% | +$99.9K |
|
4202
Kiniksa Pharmaceuticals
KNSA
$5.99B
| $2.6M | ﹤0.01% |
261,845
-94,919
| -27% | -$1.01M |
|
4203
AnaptysBio
ANAB
$1.73B
| $2.6M | ﹤0.01% |
104,991
+32,264
| +44% | +$976K |
|
|
WPS
4204
DELISTED
iShares International Developed Property ETF
WPS
| $2.6M | ﹤0.01% |
73,342
+8,885
| +14% | +$316K |
|
4205
First Merchants
FRME
$2.74B
| $2.59M | ﹤0.01% |
62,348
-26,427
| -30% | -$1.15M |
|
4206
Hayward Holdings
HAYW
$3.22B
| $2.59M | ﹤0.01% |
156,008
+14,061
| +10% | +$266K |
|
|
DSM
4207
BNY Mellon Strategic Municipal Bond Fund
DSM
$290M
| $2.59M | ﹤0.01% |
366,494
-28,623
| -7% | -$213K |
|
4208
Freedom Holding
FRHC
$9.34B
| $2.59M | ﹤0.01% |
43,462
+28,906
| +199% | +$1.81M |
|
|
JHAA
4209
DELISTED
Nuveen Corporate Income 2023 Target Term Fund
JHAA
| $2.58M | ﹤0.01% |
273,775
-359,790
| -57% | -$3.48M |
|
|
IGMS
4210
DELISTED
IGM Biosciences
IGMS
| $2.58M | ﹤0.01% |
96,590
+45,611
| +89% | +$849K |
|
4211
Nexa Resources
NEXA
$1.88B
| $2.58M | ﹤0.01% |
276,495
+82,622
| +43% | +$715K |
|
|
BKN
4212
DELISTED
BlackRock Investment Quality Municipal Trust
BKN
| $2.58M | ﹤0.01% |
179,387
+18,537
| +12% | +$296K |
|
4213
Olema Pharmaceuticals
OLMA
$930M
| $2.58M | ﹤0.01% |
605,260
+12,935
| +2% | +$71.3K |
|
|
RVI
4214
DELISTED
Retail Value Inc. Common Shares
RVI
| $2.58M | ﹤0.01% |
842,758
-85,972
| -9% | -$271K |
|
4215
Sotera Health
SHC
$5.39B
| $2.57M | ﹤0.01% |
118,672
-270,179
| -69% | -$5.73M |
|
4216
Clearfield
CLFD
$391M
| $2.56M | ﹤0.01% |
39,196
+5,434
| +16% | +$341K |
|
4217
Rocky Brands
RCKY
$356M
| $2.55M | ﹤0.01% |
61,373
+42,400
| +223% | +$1.81M |
|
4218
AXT Inc
AXTI
$5.35B
| $2.55M | ﹤0.01% |
363,349
+7,735
| +2% | +$58.1K |
|
|
EH
4219
EHang Holdings
EH
$450M
| $2.55M | ﹤0.01% |
212,591
-172,731
| -45% | -$2.5M |
|
4220
US Commodity Index
USCI
$375M
| $2.54M | ﹤0.01% |
46,123
+2,719
| +6% | +$137K |
|
4221
Vera Bradley
VRA
$93M
| $2.54M | ﹤0.01% |
331,608
-6,098
| -2% | -$48.2K |
|
|
ATRS
4222
DELISTED
Antares Pharma, Inc.
ATRS
| $2.54M | ﹤0.01% |
620,001
-21,652
| -3% | -$78.5K |
|
4223
INmune Bio
INMB
$60.2M
| $2.53M | ﹤0.01% |
300,481
-78,006
| -21% | -$701K |
|
|
MAGN
4224
Magnera Corp
MAGN
$444M
| $2.52M | ﹤0.01% |
15,697
+853
| +6% | +$169K |
|
4225
Nuveen Core Plus Impact Fund
NPCT
$280M
| $2.52M | ﹤0.01% |
167,728
+6,189
| +4% | +$98.8K |
|
Similar funds
Morgan Stanley's Q1 2022 Portfolio in Review
As of Q1 2022, Morgan Stanley held 8,434 positions worth $741B, down 8.4% from $810B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q1 2022 filing shows 237 new, 3,520 increased, 3,560 reduced and 255 closed positions. Its largest new stake was Shell: 4,762,346 shares worth $262M. The largest sale was Mastercard, an estimated $2.61B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2022 buy was Shell: 4,762,346 shares worth $262M.
- Morgan Stanley added most to iShares 20+ Year Treasury Bond ETF in Q1 2022, an estimated $1.86B increase.
- Morgan Stanley's biggest Q1 2022 reduction was Mastercard, cutting an estimated $2.61B.
- Morgan Stanley fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $961M.
- Morgan Stanley's ten largest holdings make up 15% of its $741B portfolio in Q1 2022.
- Morgan Stanley opened 237 new positions and closed 255 in Q1 2022.
- Morgan Stanley's portfolio value fell 8.4% quarter-over-quarter to $741B.
Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.